NCT07789574
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07789574
Title Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations (ESTIMATION)
Acronym ESTIMATION
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Thomas Ernst, Prof. Dr. med.
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.